Connect with us

Health

New York resident dies from mosquito-borne disease as experts warn of widening risk

Published

on

New York resident dies from mosquito-borne disease as experts warn of widening risk

New York has reported the state’s first death from Eastern equine encephalitis (EEE), a disease that spreads through bites from mosquitoes.

The patient was the first person to contract EEE in New York since 2015, according to a press release issued by the state on Monday.

“Keeping New Yorkers safe is my top priority,” Governor Hochul said in a statement.

WHAT IS EEE, THE MOSQUITO-BORNE DISEASE THAT KILLED A NEW HAMPSHIRE MAN?

“Following the first confirmed human case of EEE, my administration took statewide action to help protect communities – and with today’s declaration, we’re making more state resources available to local departments to support their public health response.”

Advertisement

New York has reported the state’s first death from Eastern equine encephalitis (EEE), a disease that spreads through bites from mosquitoes. (iStock)

“We’ve been informed this patient has passed away from EEE; we extend our sympathies and our hearts go out to their family.”

State Health Commissioner Dr. James McDonald has declared EEE an imminent threat to public health, which will make more resources available for prevention measures, such as spraying to reduce mosquitoes.

NORTHEASTERN TOWNS ISSUE VOLUNTARY LOCKDOWN TO PREVENT SPREAD OF MOSQUITO-BORNE DISEASE

The state has announced plans to expand access to insect repellent in parks and campgrounds, and is encouraging New York residents to take steps to protect against mosquito-borne illness.

Advertisement

What is EEE?

Eastern equine encephalitis is caused by a virus that is spread through the bite of an infected mosquito, according to the Centers for Disease Control and Prevention (CDC), which describes EEE as a “rare but serious disease.”

Only a few cases are reported in the U.S. each year, most in the Eastern or Gulf Coast states, the agency states on its website.

Some Northeastern towns have enacted voluntary lockdowns due to the rise in EEE cases. (iStock)

Humans and other animals that contract the virus are considered “dead-end hosts,” the CDC states, which means they can’t spread it to mosquitoes that bite them.

“EEE is only spread to humans via a mosquito bite, and cannot be transmitted directly by other humans or horses,” Dr. Kurt Vandock, PhD, a public health expert and VP of strategic growth for Mosquito Squad, told Fox News Digital.

Advertisement

The patient was the first person to contract EEE in New York since 2015.

Common symptoms of EEE include fever, vomiting, diarrhea, headache, stiff neck, seizures, behavioral changes and drowsiness.

These usually appear five to 10 days after being bitten.

“Most people have no symptoms; others get only a mild, flu-like illness with fever, headache and sore throat,” Vandock said. 

Using insect repellents that contain DEET can help to protect against mosquito bites, experts say. (iStock)

Advertisement

“For people with an infection of the central nervous system, a sudden fever (103º to 106º), severe headache and stiff neck can be followed quickly by seizures and coma.”

The disease can be deadly, resulting in fatalities for 30% of infected people. It can also lead to chronic neurological deficiencies, per the CDC.

ANTHONY FAUCI’S WEST NILE VIRUS DIAGNOSIS: WHAT TO KNOW ABOUT THE MOSQUITO-BORNE DISEASE

“The best way to confirm any illness is with an approved and accurate test administered by a medical professional,” said Vandock.

“Eastern equine encephalitis is a serious disease with symptoms occurring fast,” he warned.

Advertisement

“If you live in an area with noted EEE activity and have flu-like symptoms after being bitten by a mosquito, you should seek medical care immediately.”

Concerns of wider infection

In addition to New York, other states that have reported human EEE cases include Massachusetts, Vermont, New Jersey, Rhode Island, Wisconsin and New Hampshire.

“Anytime life is put at risk by vector-borne disease, we are concerned,” Vandock said.

“As viral loads increase and transmission rates follow this trend, it is a sign that interventions are necessary to help reduce the risk of transmission,” he went on. 

Common symptoms of EEE include fever, vomiting, diarrhea, headache, stiff neck, seizures, behavioral changes and drowsiness. (iStock)

Advertisement

“One case of any vector-borne disease is one too many.”

As far as why cases have been more prevalent in northeastern states, Vandock said there’s no simple answer.

“Conducive weather patterns, high population density, the heavy presence of the primary vector and seasonality — coinciding with increased outdoor activity — can create the perfect storm for rapid transmission,” he said. 

“One case of any vector-borne disease is one too many.”

The black-tailed mosquito (Culiseta melanura), the primary vector of EEE, can be found in large numbers in the Northeastern United States, according to Vandock. 

Advertisement

“It is known to feed mainly on birds, but does not typically feed on humans,” he said. “As a result, the transmission of EEE to humans and horses is generally thought to occur via ‘bridge vectors,’ which contract the virus from infected birds and can then pass the virus on to other hosts.”

      

The mosquitoes that act as “bridge vectors” can be found in the Northeast areas where transmission is occurring, the expert noted. 

The risk of contracting the EEE virus is highest during the summer months — especially toward the end of summer, when people go back outdoors as temperatures cool, Vandock said. 

The mosquitoes that act as “bridge vectors” can be found in the Northeast areas where transmission is occurring, an expert noted.  (iStock)

Advertisement

“Anyone who lives or works close to wetlands and swamps is also at an increased risk,” he said. 

The Midwest saw a similar outbreak of EEE in 2019 in Michigan, Vandock noted, as many schools canceled after-school activities after numerous fatalities from the disease. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Current trends suggest that with increasing globalization, population densities, ranges of competent hosts and a favorable climate, the occurrence of EEE and other vector-borne diseases will increase,” he added.

Dr. Marc Siegel, senior medical analyst for Fox News and clinical professor of medicine at NYU Langone Medical Center, said he is not concerned by the increase in cases.

Advertisement

“It is still a very slight uptick, and it is confined to mosquito transmission,” he told Fox News Digital, adding that he only anticipates “sparse cases” in other parts of the country.

Treatment and prevention

There is currently no vaccine for Eastern equine encephalitis, and supportive care is the only means of treating symptoms. 

A mosquito control inspector sprays pesticide to kill mosquitos amid a Zika virus outbreak in Miami, Florida, in 2016. (Getty Images)

Educating the public about the risk, encouraging mosquito repellent use, and spraying to control the mosquito population are the best ways to prevent infection, according to experts.

For more Health articles, visit www.foxnews.com/health

Advertisement

The state of New York issued the following recommendations for prevention.

  1. Wear long sleeves, pants and socks when outdoors during periods of high mosquito activity, such as dusk or dawn.
  2. Use insect repellents that contain DEET.
  3. Ensure that there are screens in all windows and doors.
  4. Eliminate standing water in outdoor areas where mosquitoes tend to breed.

Health

Ozempic-style drugs could slash complication risks after heart attacks, research suggests

Published

on

Ozempic-style drugs could slash complication risks after heart attacks, research suggests

NEWYou can now listen to Fox News articles!

A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study published this week in Nature Communications.

The research, led by the University of Bristol and University College London, identified a biological brain-gut-heart signaling pathway. 

This discovery appears to explain how GLP-1 drugs — which mimic glucagon-like peptide-1, a hormone that helps regulate blood sugar and appetite — protect heart tissue from a condition known as “no-reflow.”

“In nearly half of all heart attack patients, tiny blood vessels within the heart muscle remain narrowed, even after the main artery is cleared during emergency medical treatment,” Dr. Svetlana Mastitskaya, the study’s lead author and a senior lecturer at Bristol Medical School, said in a press release.

Advertisement

“This results in a complication known as ‘no-reflow,’ where blood is unable to reach certain parts of the heart tissue.”

In nearly half of all heart attack patients, tiny capillaries (blood vessels) remain narrowed even after the main blocked artery is cleared. (iStock)

This lack of blood flow increases the risk of heart failure and death within a year. GLP-1 medications could prevent this, according to the researchers.

How it works

When the GLP-1 hormone is released in the gut or administered as a drug, it sends a signal to the brain, which then sends a signal to the heart that switches on special potassium channels in tiny cells called pericytes.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

When these channels open, the pericytes relax, which allows the small blood vessels (capillaries) to widen and improve blood flow to the heart muscle, the researchers noted.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The new study used animal models and cellular imaging to track how GLP-1 interacts with heart tissue. When the researchers removed the potassium channels, the drugs no longer protected the heart — confirming they play a key role.

The findings suggest that existing GLP-1 medications, already used for type 2 diabetes and obesity, could be repurposed as emergency treatments. (iStock)

The findings suggest that existing GLP-1 medications, already used for type 2 diabetes and obesity, could be repurposed as emergency treatments during or immediately after a heart attack to reduce tissue damage.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The researchers noted several limitations, including that the study relied on animal models.

Clinical trials are necessary to determine whether the brain-gut-heart pathway operates with the same timing and efficacy in humans.

While the study highlights the drug’s immediate benefits during a heart attack, it des not establish whether long-term use of these drugs provides a pre-existing level of protection. (iStock)

Additionally, while the study highlights the drug’s immediate benefits during a heart attack, it does not establish whether long-term use of the medication provides a pre-existing level of protection.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The research was primarily funded by the British Heart Foundation.

Related Article

Eating oatmeal for two days has unexpected impact on heart health, study suggests
Advertisement
Continue Reading

Health

Do collagen supplements really improve skin? Major review reveals the truth

Published

on

Do collagen supplements really improve skin? Major review reveals the truth

NEWYou can now listen to Fox News articles!

Collagen supplements have exploded in popularity, touted as everything from an anti-aging miracle to a muscle recovery booster.

But a sweeping new review conducted by U.K. researchers suggests that while collagen may help improve skin elasticity and ease arthritis pain, it does little for athletic performance or wrinkle reduction.

Researchers from Anglia Ruskin University analyzed 16 systematic reviews and 113 randomized controlled trials involving nearly 8,000 participants worldwide, which they say is the most extensive evaluation of collagen’s health effects to date. 

The review found consistent evidence that collagen supplementation improves skin elasticity and hydration over time and provides significant relief from osteoarthritis-related joint pain and stiffness, according to findings published in Aesthetic Surgery Journal Open Forum. 

Advertisement

A large U.K. review found that collagen supplements may improve skin elasticity and hydration over time. (iStock)

The researchers, however, did not find meaningful improvements in post-exercise muscle recovery, soreness or tendon mechanical properties (strength, springiness and stretch resistance).

“Collagen is not a cure-all, but it does have credible benefits when used consistently over time, particularly for skin and osteoarthritis,” co-author Lee Smith, professor of public health at Anglia Ruskin University, said in a statement.

EXPERIMENTAL SERUM SHOWS PROMISE IN REVERSING BALDNESS WITHIN 20 DAYS

“Our findings show clear benefits in key areas of healthy aging, while also dispelling some of the myths surrounding its use,” Smith added.

Advertisement

Collagen, the most abundant protein in the body, supports skin, bones, tendons, cartilage and connective tissue, according to experts. Natural collagen production begins to drop in early adulthood and declines more sharply with age.

The study found that collagen supplements may help reduce joint pain and stiffness in people with osteoarthritis. (iStock)

The review found that long-term collagen supplementation was linked to improved skin firmness and hydration, but did not help skin roughness — a proxy for visible wrinkles. 

Benefits appear to accumulate gradually, suggesting that collagen should not be viewed as an “anti-wrinkle ‘quick fix,’ but as a foundational dermal support for individuals seeking holistic skin maintenance,” the researchers said.

Advertisement

“If we define anti-aging as a product or technique designed to prevent the appearance of getting older, then I believe our findings do support this claim for some parameters,” Smith told the BBC. “For example, an improvement in skin tone and moisture is associated with a more youthful-looking appearance.”

Collagen supplementation was linked to reduced pain and stiffness in people with osteoarthritis, with stronger benefits seen over longer periods of use, and showed modest improvements in muscle mass and tendon structure that may support healthy aging. 

Collagen did not significantly improve skin roughness, a marker of visible wrinkles. (iStock)

However, it did not show meaningful results when used as a fast-acting sports performance supplement, and evidence for benefits related to cholesterol, blood sugar, blood pressure and oral health was mixed or inconclusive.

Dr. Daniel Ghiyam, a California-based physician and longevity specialist, said the findings align with what he sees in clinical practice.

Advertisement

CLICK HERE FOR MORE LIFESTYLE STORIES

“Collagen is a targeted support tool, not a foundation of health or performance,” Ghiyam, who was not involved in the study, told Fox News Digital. “When marketed that way, it makes sense. When marketed as a cure-all, it doesn’t hold up to the data.”

The authors noted that while many previous collagen studies have received financial support from the supplement industry, the current review did not receive industry funding.

Experts say collagen supplements may offer modest benefits for skin hydration and joint comfort, but they are not a cure-all. (iStock)

The team called for more high-quality clinical trials examining long-term outcomes, optimal dosages and differences between collagen sources, such as marine, bovine and plant-based alternatives. 

Advertisement

Among its limitations, the review could not determine whether certain forms of collagen work better than others or what the optimal regimen should be. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

While the review included randomized controlled trials, the quality of the studies varied, with newer research generally showing stronger results.

Experts say more data and studies are needed to build on the findings. They also noted that diet plays a crucial role in skin health.

Collagen supplements, often sold as powders or pills, may improve skin elasticity and ease joint pain, experts say. (iStock)

Advertisement

Dr. Erum Ilyas, a Pennsylvania-based dermatologist and chair of dermatology at Drexel University College of Medicine, noted that the review analyzed previously published meta-analyses rather than generating new primary data.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“At this time, I have not seen sufficiently strong independent evidence to routinely recommend collagen supplements to my patients,” Ilyas, who was not involved in the review, told Fox News Digital.

“Although some studies show modest improvements in markers such as hydration and elasticity, there remains limited independent, biopsy-confirmed evidence demonstrating sustained increases in dermal collagen content,” she added.

Fox News Digital has reached out to the researchers for comment.

Advertisement

Related Article

Cosmetic fillers can cause deadly complication, experts warn — but new tech exposes it
Continue Reading

Health

Origin of deadly cancer affecting young adults revealed in alarming report

Published

on

Origin of deadly cancer affecting young adults revealed in alarming report

NEWYou can now listen to Fox News articles!

As colorectal cancer (CRC) is now the leading cause of cancer death in adults under 50, a new report reveals some surprising shifts in the incidence of the disease.

Although rates of CRC have been declining among seniors, those 65 and under are facing a rise in diagnoses, according to a report titled Colorectal Cancer Statistics, 2026, from the American Cancer Society.

Adults 65 and younger comprise nearly half (45%) of all new colorectal cancer cases — a significant increase from 27% in 1995, states the report, which was published in CA: A Cancer Journal for Clinicians.

The disease is rising fastest among adults 20 to 49 years old, at a rate of 3% per year.

Advertisement

Colorectal cancer is now the leading cause of cancer death in adults under 50. (iStock)

Among adults 50 and under, 75% of colorectal cancers are diagnosed at an advanced stage. Half of the diagnoses in that age range are made between the ages of 45 and 49. Although that age group is eligible to receive routine screenings, just 37% do so.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The report also revealed that rectal cancer is on the rise, now accounting for about one-third (32%) of all CRC cases — an increase from 27% in the mid-2000s.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

“After decades of progress, the risk of dying from colorectal cancer is climbing in younger generations of men and women, confirming a real uptick in disease because of something we’re doing or some other exposure,” said Rebecca Siegel, senior scientific director, surveillance research at the American Cancer Society and lead author of the report, in a press release.

Among adults 50 and under, 75% of colorectal cancers are diagnosed at an advanced stage. Half of the diagnoses in that age range are made between the ages of 45 and 49.  (iStock)

“We need to redouble research efforts to understand the cause, but also circumvent deaths through earlier detection by educating clinicians and the general public about symptoms and increasing screening in people 45-54 years.”

It is projected that 158,850 new cases of colorectal cancer will be diagnosed this year, and that the disease will cause 55,230 deaths, per the report.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

More than half of CRC cases can be linked to high-risk behaviors, the researchers said. Those include lack of nutrition, high alcohol consumption, smoking, lack of exercise and obesity.

“These findings further underscore that colorectal cancer is worsening among younger generations and highlight the immediate need for eligible adults to begin screening at the recommended age of 45,” said Dr. William Dahut, chief scientific officer at the American Cancer Society.

When the disease is caught at a local (early) stage, the five-year survival rate is 95%. (iStock)

“The report also shines a light on the crucial importance of continued funding for research to help discover new therapies to treat the disease and advance patient care.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

When the disease is caught at a local (early) stage, the five-year survival rate is 95%, the report stated.

Related Article

Hidden virus inside gut bacteria linked to doubled colorectal cancer risk, study finds
Continue Reading
Advertisement

Trending